Utilizing Reinforcement Learning for de novo Drug Design
Deep learning-based approaches for generating novel drug molecules with specific properties have gained a lot of interest in the last few years. Recent studies have demonstrated promising performance for string-based generation of novel molecules utilizing reinforcement learning. In this paper, we develop a unified framework for using reinforcement learning for de novo drug design, wherein we systematically study various on- and off-policy reinforcement learning algorithms and replay buffers to learn an RNN-based policy to generate novel molecules predicted to be active against the dopamine receptor DRD2. Our findings suggest that it is advantageous to use at least both top-scoring and low-scoring molecules for updating the policy when structural diversity is essential. Using all generated molecules at an iteration seems to enhance performance stability for on-policy algorithms. In addition, when replaying high, intermediate, and low-scoring molecules, off-policy algorithms display the potential of improving the structural diversity and number of active molecules generated, but possibly at the cost of a longer exploration phase. Our work provides an open-source framework enabling researchers to investigate various reinforcement learning methods for de novo drug design.
Code (1)
Tasks
DiversityDrug Designreinforcement-learningReinforcement LearningSimilar Papers 제목 키워드 기반
De novo Drug Design using Reinforcement Learning with Multiple GPT Agents
De novo drug design is a pivotal issue in pharmacology and a new area of focus in AI for science research. A central challenge in this field is to generate molecules with specific properties while also producing a wide r…
DiversityDrug Designreinforcement-learningReinforcement LearningImproving Targeted Molecule Generation through Language Model Fine-Tuning Via Reinforcement Learning
Developing new drugs is laborious and costly, demanding extensive time investment. In this paper, we introduce a de-novo drug design strategy, which harnesses the capabilities of language models to devise targeted drugs …
Drug DesignLanguage ModelingLanguage ModellingReinforcement Learning (RL)ReACT-Drug: Reaction-Template Guided Reinforcement Learning for de novo Drug Design
De novo drug design is a crucial component of modern drug development, yet navigating the vast chemical space to find synthetically accessible, high-affinity candidates remains a significant challenge. Reinforcement Lear…
Representation LearningReinforcement LearningWidely Used and Fast De Novo Drug Design by a Protein Sequence-Based Reinforcement Learning Model
De novo molecular design has facilitated the exploration of large chemical space to accelerate drug discovery. Structure-based de novo method can overcome the data scarcity of active ligands by incorporating drug-target …
Drug DesignDrug DiscoveryMolecular DockingReinforcement Learning (RL)Reinforcement Learning for Personalized Drug Discovery and Design for Complex Diseases: A Systems Pharmacology Perspective
Many multi-genic systemic diseases such as neurological disorders, inflammatory diseases, and the majority of cancers do not have effective treatments yet. Reinforcement learning powered systems pharmacology is a potenti…
Drug DesignDrug Discoveryreinforcement-learningReinforcement Learning+1